Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open-label Extension Phase to Study the Long-term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia

NCT00110968 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00110968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00110968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open-label Extension Phase to Study the Long-term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
September 30, 2006
Enrollment
300
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia